ArticleScientific reports2026
A multi-level attention CNN-transformer based framework for the detection of brain tumor using regional dual-score explainability.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Deep learning models for brain tumor diagnosis often lack interpretability beyond qualitative visual heatmaps. Clinicians require not only tumor localization but also quantitative assessment of explanation quality and diagnostic relevance, capabilities absent in conventional explainability methods. This paper introduces a classification-explainability framework addressing these limitations. The Multi-Level Hybrid Network (MLHnet) integrates CNN-Transformer components with multi-level attention for robust feature learning. The key novelty lies in the Dual-Score Regional XAI framework, which: (1) identifies tumor regions using hybrid saliency maps combining gradient-based and activation-based information; (2) quantifies geometric tumor characteristics via a Shape Score capturing size, circularity, and saliency concentration; and (3) evaluates explanation faithfulness using regional perturbation analysis, measuring prediction sensitivity to tumor-specific versus non-tumor regions. The framework is evaluated on a publicly available brain Magnetic Resonance Imaging (MRI) dataset containing 7,023 images across four classes. Using five‑fold cross‑validation, the proposed model achieves an average test accuracy of 99.30% (best fold: 99.47%). Expert radiologist evaluation confirms 87.64% explanation correctness, with the Dual-Score metrics successfully differentiating tumor classes based on morphological and saliency patterns. Overall, the proposed framework offers a lightweight, high-performing, and interpretable solution for reliable brain tumor diagnosis from MRI scans on the evaluated public dataset.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.